Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

JERSEY SHORE REGIONAL HEALTH COMMISSION

UEI: W63CPRPZLGE6CAGE: 9BH82

JERSEY SHORE REGIONAL HEALTH COMMISSION is a federal contractor, registered under UEI W63CPRPZLGE6 and CAGE code 9BH82. It has been awarded $1,207,567 in federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services (hhs).

Contact Information

Registration and classification details

Registration

UEI Code

W63CPRPZLGE6

CAGE Code

9BH82

Entity Structure

U.S. Government Entity

Established

N/A

Business Classifications

Local Government OwnedU.S Local Government

NAICS Codes

923120Administration of Public Health Programs(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

JERSEY SHORE REGIONAL HEALTH COMMISSION operates as a public health governance entity focused on regional health system coordination and public health service delivery. Its core capabilities center on public health program administration, community health planning, and interagency collaboration to a...

JERSEY SHORE REGIONAL HEALTH COMMISSION operates as a public health governance entity focused on regional health system coordination and public health service delivery. Its core capabilities center on public health program administration, community health planning, and interagency collaboration to address regional health disparities. The organization implements preventive care initiatives, disease surveillance systems, and emergency preparedness protocols under state and local public health mandates. Technical expertise includes epidemiological data analysis, health equity program design, and regulatory compliance with state health codes and CDC guidelines. Its distinguishing strength lies in its role as a regional convener, integrating services across municipal, hospital, and nonprofit partners to ensure coordinated care delivery and resource optimization. Agency experience cannot be characterized due to insufficient award history. While the entity functions within the public health ecosystem, no specific federal, state, or local agency relationships can be inferred from available data. The primary NAICS code 923120—“Public Finance Activities”—in this context reflects the commission’s function as a governmental body responsible for managing public health funding, grant administration, and health service procurement on behalf of a regional jurisdiction. This classification aligns with public health governance rather than direct clinical service provision, positioning the organization as a strategic administrator of public health infrastructure rather than a direct service contractor. The entity is structured as a 2A—state or local government agency—based in Tinton Falls, New Jersey, serving the Jersey Shore region. It holds no federal certifications and operates exclusively within the public sector, with no commercial contracting activity discernible from available records. Its market presence is confined to regional public health governance, where it fulfills statutory obligations to protect and promote community health through administrative and planning functions.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

9

All time

Active

0

Currently performing

Completed

9

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with JERSEY SHORE REGIONAL HEALTH COMMISSION

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for JERSEY SHORE REGIONAL HEALTH COMMISSION

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in JERSEY SHORE REGIONAL HEALTH COMMISSION's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The NIH Small Business Technology Transfer (STTR) grant, solicitation PA-27-102, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products in formal collaboration with non-profit research institutions. The program is designed to enhance health and reduce illness through a phased approach: Phase I focuses on establishing technical merit and feasibility, while Phase II advances the research toward commercialization. Eligible applicants include U.S.-owned and operated for-profit organizations with 500 or fewer employees. The NIH also offers Fast-Track applications to combine both phases and Direct to Phase II awards for businesses that have already demonstrated technical feasibility. Funding limits vary by the awarding NIH Institute or Center, with Phase I budgets typically ranging from 400,000 to 700,000 dollars and Phase II budgets reaching up to 3,000,000 dollars. Applications are evaluated via a peer review system based on scientific merit, commercial potential, and the team's ability to execute the project. While clinical trials are generally optional, they require a specific regulatory plan and adherence to strict safety and registration guidelines. Additionally, recipients must maintain active SAM and UEI registrations and comply with federal cybersecurity incident reporting requirements, including notifying the HHS of any breaches within 48 hours.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 5 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
The NIH, CDC, and FDA Small Business Innovation Research (SBIR) Grant, solicitation PA-27-100, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products. The program is structured in phases, with Phase I focusing on technical merit and feasibility and Phase II advancing the technology toward commercialization. Eligible applicants include for-profit U.S. businesses with no more than 500 employees. The funding opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with budget limits varying by participating institute, typically ranging from 400,000 to 700,000 dollars for Phase I and up to 3,000,000 dollars for Phase II. Applications are evaluated through a peer review system based on scientific and technical merit, significance, and the suitability of the business environment. While clinical trials are generally optional, they are prohibited for specific components, including all FDA participating components and several NIH institutes. Recipients must adhere to strict compliance requirements, including maintaining active SAM registration, disclosing foreign relationships, and implementing cybersecurity incident reporting procedures that notify agencies within 48 hours of discovery. The current solicitation remains open for applications until April 6, 2027.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 5 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, under solicitation PAR-27-098, is a funding opportunity provided by the National Institutes of Health (NIH) to help U.S.-based small business concerns transition technology from late-stage development to full commercialization. This program specifically targets recipients of prior active or ended NIH SBIR/STTR Phase II or Phase IIB Strategic Breakthrough awards. The CRP supports activities that bridge the gap to market, including late-stage research and development, independent replication of key studies, manufacturing scale-up, and technical assistance such as regulatory strategy, intellectual property planning, and market research. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in project oversight and management. Eligible projects may have a maximum performance period of three years, with budget ceilings varying by the participating NIH Institute or Center, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain institutes. Applications are evaluated via the NIH peer review system based on scientific and technical merit, commercial potential, and relevance to program priorities. Key requirements for applicants include maintaining active SAM and UEI registrations and submitting a detailed regulatory plan and progress report. It is important to note that while clinical trials are generally optional, several NIH components, including the NHLBI, NIAID, and NIDDK, do not accept clinical trials under this specific funding opportunity. Additionally, funds cannot be used for patent or FDA filing fees, nor can they include separate Technical and Business Assistance funding.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 5 months
View Details